National Institutes of Health Chooses Blue Heron Biotechnology In Emergency Response to Swine Flu Threat

BOTHELL, Wash.--BLUE HERON BIOTECHNOLOGY announced today that it delivered a critical synthetic DNA gene sequence in just three days in response to the National Institutes of Health request for assistance in combating the outbreak of Swine Flu. “We are gratified that the NIH has placed their confidence and trust in Blue Heron in this time [...]

New Workspace Protects Microarrays from Harmful Ozone

Creates an Ozone-Safe Environment for Automated or Manual Microarray Processing May 01, 2009, SciGene (Sunnyvale, CA) today announced the introduction of the NoZone® WS Workspace, a new benchtop system for maintaining an ozone-safe environment when operating microarray scanning and processing equipment. The workspace consists of a benchtop polycarbonate enclosure with an external high efficiency ozone [...]

Law Offices of Howard G. Smith Announces Investigation On Behalf of Investors of Sequenom, Inc.

BENSALEM, Pa.--Law Offices of Howard G. Smith announces that it is investigating potential claims against Sequenom, Inc. (“Sequenom” or the “Company”) (Nasdaq:SQNM - News), concerning possible securities violations related to public statements made by the Company between June 4, 2008 and April 29, 2009. The investigation focuses on allegations that certain statements made by the [...]

Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Sequenom, Inc.

BALA CYNWYD, PA--May 1, 2009 -- Law office of Brodsky & Smith, LLC announces that a class action lawsuit has been filed on behalf of all persons who purchased common stock of Sequenom, Inc. ("Sequenom" or the "Company") (NasdaqGM:SQNM - News) between June 4, 2008 and April 29, 2009 (the "Class Period"). The class action [...]

MaxCyte GT Flow Transfection System Now Available to Academic and Clinical Investigators

cGMP-Compliant, Validated Technology Enhances Biological Activity Enabling Clinical Delivery of Safe and Effective Cellular Therapeutics GAITHERSBURG, Md.--MaxCyte today announces the launch of the MaxCyte® GT™ Flow Transfection System to academic and clinical investigators. The MaxCyte® GT™ Flow Transfection System is a validated platform for optimizing the biological activity of cellular therapeutic products. The system, which [...]

Real-Time and Dynamic Monitoring of Virus-Mediated Cytopathogenicity with Roche´s xCELLigence System

PENZBERG, Germany--To understand overall infectivity, virus progression and disease-onset it is important to perform a detailed examination of cytopathogenic effects. Depending on the type of virus and cells as well as the time point of infection (e.g. during the growth or the stationary phase) different cytopathogenic effects might be observed. One of the most common [...]

Analytik Jena acquires 100% stake in Biometra GmbH, Göttingen

- Well-known player in the growing market segment substantially strengthens life sciences portfolio of Analytik Jena - Innovative products of Analytik Jena meet a well-positioned worldwide distribution network in over 60 countries Jena / Goettingen, 30 April 2009 - Analytik Jena AG (Frankfurt, Prime Standard: AJA), a manufacturer and distributor of analytical and bioanalytical systems [...]

Alpha M.O.S. Sales for 1st Half Year 2008-2009

SALES FOR 1st HALF YEAR 2008-2009 : GOOD SECOND QUARTER: + 39 % BUT GROWTH FOR FIRST HALF LOWER THAN FORECAST Toulouse, April 30, 2009 – Alpha M.O.S., (Euronext Paris, compartment C, ISIN : FR0000062804-ALM) world leader in the manufacture of electronic noses and tongues for industrial applications, generated sales of € 2,626 million during [...]

Moving promising drug candidates to clinical trials faster and more reliably…

Symyx Technologies, Inc. has announced the launch of the Symyx Contract Development and Manufacturing Organisation (CDMO). The Symyx CDMO (https://www.symyx.com/CDMO) helps biopharmaceutical companies move promising drug candidates to clinical trials faster and more reliably with integrated formulation development, and preclinical and CGMP fill/finish manufacturing. "After discovery, the next critical milestone in drug development is getting [...]

QIAGEN Tests Clinically Verified for the Monitoring of Swine Flu

KJ VENLO, GERMANY--Apr 30, 2009 -- German Bernhard Nocht Institute and Spanish Reference Laboratory Unequivocally Detect Infections with the H1N1 Strain Using the artus Influenza Test Venlo, The Netherlands - April 30, 2009 - Analyses performed by the German Bernhard Nocht Institute for Tropical Medicine have proven that the influenza A / H1N1 virus can [...]

Access IBO on Knowledge Center